Tarsus Pharmaceuticals (NASDAQ:TARS – Get Free Report) posted its earnings results on Tuesday. The company reported ($1.31) earnings per share for the quarter, beating the consensus estimate of ($1.37) by $0.06, MarketWatch Earnings reports. The company had revenue of $13.08 million for the quarter, compared to analysts’ expectations of $4.63 million. During the same period […]
Tarsus Pharmaceuticals, Inc (NASDAQ:TARS) to Post FY2028 Earnings of $5 58 Per Share, HC Wainwright Forecasts theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report)’s stock price was up 6.9% during trading on Monday . The stock traded as high as $25.14 and last traded at $25.09. Approximately 256,180 shares changed hands during mid-day trading, a decline of 60% from the average daily volume of 644,086 shares. The stock had previously closed […]
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report)’s share price rose 6.9% during trading on Monday . The company traded as high as $25.14 and last traded at $25.09. Approximately 256,180 shares traded hands during mid-day trading, a decline of 60% from the average daily volume of 644,086 shares. The stock had previously closed at […]
Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) gapped down prior to trading on Thursday . The stock had previously closed at $23.42, but opened at $22.81. Tarsus Pharmaceuticals shares last traded at $23.36, with a volume of 57,660 shares trading hands. Analyst Upgrades and Downgrades Several brokerages recently weighed in on TARS. […]